BLC0271 - Drug Testing On Arrest - Market Engagement Notice

BlueLight Commercial Limited, a sub-central government authority located in London, has initiated the planning stage for a procurement process titled "BLC0271 - Drug Testing On Arrest - Market Engagement Notice." This tender focuses on goods within the healthcare and drug testing industry, specifically aiming at enhancing the police Drug Testing on Arrest programme. The planning involves obtaining market information to replace the current procurement framework with a more effective and reliable solution.

Important dates include a deadline of 3rd October 2025 for the initial written response, followed by virtual meetings scheduled between 13th and 15th October 2025. The market engagement survey will remain open until shortly before the tender is officially published. The contract period is anticipated to start on 1st October 2026 and end on 30th September 2029, with the potential for renewal up to September 2030.

This tender represents significant growth opportunities for businesses in the laboratory and healthcare sectors, particularly those specialising in drug detection and testing apparatus, laboratory reagents, and related health services. Companies that are adept at providing innovative and effective technological solutions in drug testing would be well-suited for this procurement. The engagement process aims to refine the procurement strategy by understanding market capabilities, supplier interest, and identifying any potential risks.

Small and medium-sized enterprises (SMEs), as well as voluntary, community, and social enterprises (VCSEs), are encouraged to participate, aligning with BlueLight Commercial's commitment to fostering a diverse supplier base. This engagement will ensure participating businesses have the opportunity to influence the procurement vehicle design and optimise their chances for successful participation when the tender is published.